RSV vaccine protected infants from severe cases, Pfizer study shows
An experimental vaccine from Pfizer Inc. significantly reduced the risk of infants developing severe cases of a respiratory virus that kills hundreds of children each year, according to the company. Among mothers who received the respiratory syncytial virus vaccine, their infants had an 81.8% lower risk of developing serious lower respiratory infections that required medical … Read more